Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3942

Sort by

Sort Order Select

Journal Articles

Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies

Blood blood.2025031409.

https://doi.org/10.1182/blood.2025031409

Published: 2026

Includes: Supplemental data

Journal Articles

Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment

Bethany Verkamp, Michael B. Jordan, Carl E Allen

Blood blood.2025028762.

https://doi.org/10.1182/blood.2025028762

Published: 2026

Journal Articles

Mechanisms of immune escape and extramedullary tropism in leukemia cutis

Livius Penter, Katie Maurer, Nicoletta Cieri, Wesley S. Lu, Haoxiang Lyu, Mischa Selig, Maria Joosten, Jana Ihlow, Shuqiang Li, Kenneth J. Livak, Lars Bullinger, Jerome Ritz, Pavan Bachireddy, Matthew S. Davids, Jacqueline S. Garcia, Robert J. Soiffer, Catherine J. Wu

Blood (2026) 147 (1): 35–47.

https://doi.org/10.1182/blood.2025029121

Published: 2026

Includes: Supplemental data

Journal Articles

CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

Blood (2025) 146 (26): 3163–3174.

https://doi.org/10.1182/blood.2025029532

Published: 2025

Includes: Supplemental data

Journal Articles

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody

Nathan M. Newton, Kriti Agrawal, Anahi V. Odell, Timothy Tracy, Craig Hackett, Anne Eldrup, Michael Whitfield, Viktor Martyanov, Michael Girardi, Esen Sefik, Richard A. Flavell, Ian D. Odell

Blood (2025) 146 (26): 3201–3212.

https://doi.org/10.1182/blood.2025029836

Published: 2025

Includes: Supplemental data

Journal Articles

Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?

Christian P. Jaworek, Paul J. Bröckelmann

Blood (2025) 146 (26): 3145–3152.

https://doi.org/10.1182/blood.2025029935

Published: 2025

Journal Articles

Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma

Blood blood.2025031476.

https://doi.org/10.1182/blood.2025031476

Published: 2025

Includes: Supplemental data

Journal Articles

Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiency

Jacob A. Myers, Rih-Sheng Huang, Shee Kwan Phung, Jeremy M. Chacón, Laura Bendzick, Anna Weis, Mihir Shetty, Taylor A. DePauw, Melissa J. Khaw, Juan E. Abrahante, Stephen D. O’Flanagan, K. Maude Ashby, John R. Lozada, Stephen C. Jameson, Justin H. Hwang, Frank Cichocki, Martin Felices, Jeffrey S. Miller

Blood (2025) 146 (25): 3059–3071.

https://doi.org/10.1182/blood.2024027763

Published: 2025

Includes: Supplemental data

Journal Articles

An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden

Erin W. Meermeier, Kirsten Pfeffer, Caleb K. Stein, Meaghen E. Sharik, Megan T. Du, Yuliza Tafoya Alvarado, Chang-Xin Shi, Yuan Xiao Zhu, P. Leif Bergsagel, Marta Chesi

Blood (2025) 146 (25): 3072–3085.

https://doi.org/10.1182/blood.2025029215

Published: 2025

Includes: Supplemental data

Journal Articles

Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients

Stephanie T. Isaac, David C. Bishop, Fahad Shaikh, Kenneth Micklethwaite, David J. Gottlieb, Emily Blyth

Blood (2025) 146 (25): 3124–3128.

https://doi.org/10.1182/blood.2025029057

Published: 2025

Journal Articles

Platelet heterogeneity: variety makes immune and vascular function better

Michael W. Malloy, Kathleen E. McGrath, Craig N. Morrell

Blood (2025) 146 (24): 2882–2888.

https://doi.org/10.1182/blood.2025028955

Published: 2025

Journal Articles

Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study

Blood (2025) 146 (24): 2902–2913.

https://doi.org/10.1182/blood.2025029360

Published: 2025

Includes: Supplemental data

Journal Articles

Reprogramming glutamine metabolism enhances BCMA -CAR T-cell fitness and therapeutic efficacy in multiple myeloma

Blood (2025) 146 (24): 2931–2944.

https://doi.org/10.1182/blood.2024027496

Published: 2025

Includes: Supplemental data

Journal Articles

Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4 + T cells

Hrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo, Miriam Arroyo, Lynn Heltemes-Harris, Todd P. Knutson, Yinjie Qiu, Allison Haaning, Beau R. Webber, Veronika Bachanova, Michael A. Farrar, Sean I. Tracy

Blood (2025) 146 (23): 2779–2793.

https://doi.org/10.1182/blood.2024028194

Published: 2025

Includes: Supplemental data

Journal Articles

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial

Blood (2025) 146 (23): 2745–2757.

https://doi.org/10.1182/blood.2025029299

Published: 2025

Includes: Supplemental data

Journal Articles

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Duneia McManus, Sabrina N. Copsel, Brent J. Pfeiffer, Dietlinde Wolf, Henry Barreras, Symon Ma, Ali Khodor, Seitaro Komai, Marina Burgos da Silva, Hajar Hazime, Miguel Gallardo, Sarah Grace Lime, Marcel R. M. van den Brink, Jung-Hyun Park, Maria T. Abreu, Geoffrey R. Hill, Victor L. Perez, Robert B. Levy

Blood (2025) 146 (22): 2710–2727.

https://doi.org/10.1182/blood.2025028418

Published: 2025

Includes: Supplemental data

Journal Articles

Innate lymphoid cells prevent graft-versus-host disease via IL-9–driven T-cell senescence

Dejene M. Tufa, Eric Hoffmeyer, Kristin L. Schaller, Ben Kooiman, Elena Woods, Dong Wang, Dallas Jones, Spencer Hall, Joselyn Cruz Cruz, Michael R. Verneris

Blood (2025) 146 (22): 2656–2669.

https://doi.org/10.1182/blood.2025028504

Published: 2025

Includes: Supplemental data

Journal Articles

Prostaglandins in cancer revisited: principles of production, mechanisms of immune regulation, and therapeutic perspectives

Erik Müller, Bastian Kruse, Jan P Böttcher

Blood blood.2025029806.

https://doi.org/10.1182/blood.2025029806

Published: 2025

Journal Articles

Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine

Hitomi Hosoya, Armando N Bastidas Torres, Sebastian Fernandez-Pol, John Mark Gubatan, Safa Najidh, George E Duran, Fei Dong, Zachary Ehlinger, Claire Lohman, Charles Wright, III, Bita Sahaf, Crystal L. Mackall, David B Miklos, Surbhi Sidana, David M Kurtz, Michael S Khodadoust, Lehka Mikkilineni

Blood blood.2025031423.

https://doi.org/10.1182/blood.2025031423

Published: 2025

Includes: Supplemental data

Journal Articles

Pooled CAR-T screening in pig-tailed macaques identifies designs with enhanced proliferation, trafficking, and persistence

Blood (2025) 146 (21): 2531–2543.

https://doi.org/10.1182/blood.2025028683

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies

Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment

Mechanisms of immune escape and extramedullary tropism in leukemia cutis

CD371-targeted CAR T cells secreting interleukin-18 exhibit robust expansion and clear refractory acute myeloid leukemia

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody

Feasibility and safety of anti-PD1 first-line treatment of classic Hodgkin lymphoma: do we see the full picture?

Time of Day of CAR T-Cell Infusion and Outcomes in Large B-Cell Lymphoma

Chronic NK cell activation results in a dysfunctional, tissue resident–like state mediated by KLF2 deficiency

An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden

Human herpesvirus 6 viremia and encephalitis in CAR T-cell recipients

Platelet heterogeneity: variety makes immune and vascular function better

Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study

Reprogramming glutamine metabolism enhances BCMA -CAR T-cell fitness and therapeutic efficacy in multiple myeloma

Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4 + T cells

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Innate lymphoid cells prevent graft-versus-host disease via IL-9–driven T-cell senescence

Prostaglandins in cancer revisited: principles of production, mechanisms of immune regulation, and therapeutic perspectives

Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine

Pooled CAR-T screening in pig-tailed macaques identifies designs with enhanced proliferation, trafficking, and persistence

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only